Potential protective effects of antihypertensive treatments during the Covid-19 pandemic: from inhibitors of the renin-angiotensin system to beta-adrenergic receptor blockers

被引：12
|
作者：
Kjeldsen, Sverre E. [1 ,2 ]
Narkiewicz, Krzysztof [3 ]
Burnier, Michel [4 ]
Oparil, Suzanne [5 ]
机构：
[1] Univ Oslo, Ullevaal Hosp, Dept Cardiol, Oslo, Norway
[2] Univ Oslo, Ullevaal Hosp, Dept Nephrol, Oslo, Norway
[3] Med Univ Gdansk, Dept Hypertens & Diabetol, Gdansk, Poland
[4] CHU Vaudois, Serv Nephrol & Hypertens, Lausanne, Switzerland
[5] Univ Alabama Birmingham, Vasc Biol & Hypertens Program, Dept Med, Birmingham, AL USA
来源：
BLOOD PRESSURE | 2021年 / 30卷 / 01期
关键词：
DRUGS;
D O I：
10.1080/08037051.2021.1862483
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：1 / 3
页数：3
相关论文
共 50 条
  • [41] Renin-angiotensin system blockers and outcomes during hydroxychloroquine treatment in patients hospitalized for COVID-19 pneumonia
    Di Tano, Giuseppe
    De Maria, Renata
    Loffi, Marco
    Moschini, Luigi
    Galeazzi, Gianluca
    Danzi, Gian Battista
    REVISTA ESPANOLA DE CARDIOLOGIA, 2020, 73 (11): : 964 - 966
  • [42] Renin-angiotensin system polymorphisms as potential modifier in COVID-19 outcome
    Sabater Molina, Maria
    Nicolas Rocamora, Elisa
    Iborra Bendicho, Asuncion
    Garcia Vazquez, Elisa
    Dominguez Rodriguez, Fernando
    Barriales Villa, Roberto
    Zorio, Esther
    Gil Ortuno, Cristina
    Munoz Esparza, Carmen
    Isabel Rodriguez, Ana
    Jara Rubio, Ruben
    Moreno, Antonio
    Marcos Rodriguez, Pedro Jorge
    Garcia Pavia, Pablo
    Gimeno Blanes, Juan Ramon
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2022, 30 (SUPPL 1) : 601 - 601
  • [43] Potential Roles of the Renin-Angiotensin System in the Pathogenesis and Treatment of COVID-19
    Lu, Ling
    Liu, Xiaomei
    Jin, Rong
    Guan, Renzheng
    Lin, Rongjun
    Qu, Zhenghai
    BIOMED RESEARCH INTERNATIONAL, 2020, 2020
  • [44] In reply- Association of Renin-Angiotensin System Blockers with Outcomes in Patients With COVID-19
    Sanchis-Gomar, Fabian
    Lavie, Carl J.
    Perez-Quilis, Carme
    Henry, Brandon M.
    Lippi, Giuseppe
    MAYO CLINIC PROCEEDINGS, 2020, 95 (11) : 2561 - 2563
  • [45] Is there enough evidence to discontinue the renin-angiotensin system inhibitors in patients with COVID-19?
    Bobkova, Irina
    Kamyshova, Elena
    Rudenko, Tatiana
    Stavrovskaya, Ekaterina
    Moiseev, Sergey
    MEDICAL HYPOTHESES, 2020, 143
  • [46] Renin-angiotensin system inhibitors and mortality among diabetic patients with STEMI undergoing mechanical reperfusion during the COVID-19 pandemic
    De Luca, Giuseppe
    Nardin, Matteo
    Algowhary, Magdy
    Uguz, Berat
    Oliveira, Dinaldo C.
    Ganyukov, Vladimir
    Zimbakov, Zan
    Cercek, Miha
    Jensen, Lisette Okkels
    Loh, Poay Huan
    Calmac, Lucian
    Ferrer, Gerard Roura
    Quadros, Alexandre
    Milewski, Marek
    di Uccio, Fortunato Scotto
    von Birgelen, Clemens
    Versaci, Francesco
    Ten Berg, Jurrien
    Casella, Gianni
    Lung, Aaron Wong Sung
    Kala, Petr
    Gil, Jose Luis Diez
    Carrillo, Xavier
    Dirksen, Maurits
    Becerra-Munoz, Victor M.
    Lee, Michael Kang-yin
    Juzar, Dafsah Arifa
    Joaquim, Rodrigo de Moura
    Paladino, Roberto
    Milicic, Davor
    Davlouros, Periklis
    Bakraceski, Nikola
    Zilio, Filippo
    Donazzan, Luca
    Kraaijeveld, Adriaan
    Galasso, Gennaro
    Lux, Arpad
    Marinucci, Lucia
    Guiducci, Vincenzo
    Menichelli, Maurizio
    Scoccia, Alessandra
    Yamac, Aylin Hatice
    Mert, Kadir Ugur
    Rios, Xacobe Flores
    Kovarnik, Tomas
    Kidawa, Michal
    Moreu, Jose
    Flavien, Vincent
    Fabris, Enrico
    Martinez-Luengas, Inigo Lozano
    DIABETES EPIDEMIOLOGY AND MANAGEMENT, 2021, 4
  • [47] Angiotensin-Converting-Enzyme 2 and Renin-Angiotensin System Inhibitors in COVID-19: An Update
    Ashwin Kumar Shukla
    Monisha Banerjee
    High Blood Pressure & Cardiovascular Prevention, 2021, 28 : 129 - 139
  • [48] Angiotensin-Converting-Enzyme 2 and Renin-Angiotensin System Inhibitors in COVID-19: An Update
    Shukla, Ashwin Kumar
    Banerjee, Monisha
    HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION, 2021, 28 (02) : 129 - 139
  • [49] Effects of angiotensin receptor blockers and angiotensin-converting enzyme inhibitors on COVID-19
    Xiao-Long Li
    Tao Li
    Qi-Cong Du
    Li Yang
    Kun-Lun He
    World Journal of Clinical Cases, 2021, 9 (20) : 5462 - 5469
  • [50] Effects of angiotensin receptor blockers and angiotensin-converting enzyme inhibitors on COVID-19
    Li, Xiao-Long
    Li, Tao
    Du, Qi-Cong
    Yang, Li
    He, Kun-Lun
    WORLD JOURNAL OF CLINICAL CASES, 2021, 9 (20) : 5462 - 5469
12345